Literature DB >> 10191281

Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

D C Pimenta1, J Chao, L Chao, M A Juliano, L Juliano.   

Abstract

We have explored in detail the determinants of specificity for the hydrolysis by human tissue kallikrein (hK1) of substrates containing the Phe-Phe amino acid pair, after which hK1 cleaves kallistatin (human kallikrein-binding protein), a specific serpin for this protease, as well as somatostatin 1-14. Internally quenched fluorogenic peptides were synthesized with the general structure Abz-peptidyl-EDDnp [Abz, o-aminobenzoic acid; EDDnp, N-(2, 4-dinitrophenyl)ethylenediamine], based on the natural reactive-centre loop sequence of kallistatin from P9 to P'13, and the kinetic parameters of their hydrolysis by hK1 were determined. All these peptides were cleaved after the Phe-Phe pair. For comparison, we have also examined peptides containing the reactive-centre loop sequences of human protein-C inhibitor (PCI) and rat kallikrein-binding protein, which were hydrolysed after Phe-Arg and Leu-Lys bonds, respectively. Hybrid peptides containing kallistatin-PCI sequences showed that the efficiency of hK1 activity on the peptides containing kallistatin and PCI sequences depended on both the nature of the P1 amino acid as well as on residues at the P- and P'-sides. Moreover, we have made systematic modifications on the hydrophobic pair Phe-Phe, and on Lys and Ile at the P3 and P4 positions according to the peptide substrate, Abz-AIKFFSRQ-EDDnp. All together, we concluded that tissue kallikrein was very effective on short substrates that are cleaved after the Phe-Arg pair; however, hydrolysis after Phe-Phe or other hydrophobic pairs of amino acids was more restrictive, requiring additional enzyme-substrate interaction and/or particular substrate conformations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191281      PMCID: PMC1220179     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.

Authors:  H Kato; K Enjyoji; T Miyata; I Hayashi; S Oh-ishi; S Iwanaga
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

3.  Refined 2.5 A X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin-pancreatic trypsin inhibitor complex.

Authors:  Z Chen; W Bode
Journal:  J Mol Biol       Date:  1983-02-25       Impact factor: 5.469

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

5.  Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin.

Authors:  M J Nicklin; A J Barrett
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

6.  Active-site titration of horse urinary kallikrein.

Authors:  C A Sampaio; M U Sampaio; E S Prado
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1984-03

7.  A Met-enkephalin-containing-peptide, BAM 22P, as a novel substrate for glandular kallikreins.

Authors:  E S Prado; L Prado de Carvalho; M S Araujo-Viel; N Ling; J Rossier
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

8.  Measurement of urinary kallikrein activity. Species differences in kinin production.

Authors:  F Alhenc-Gelas; J Marchetti; J Allegrini; P Corvol; J Menard
Journal:  Biochim Biophys Acta       Date:  1981-11-05

9.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.

Authors:  H Loebermann; R Tokuoka; J Deisenhofer; R Huber
Journal:  J Mol Biol       Date:  1984-08-15       Impact factor: 5.469

10.  Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

Authors:  D Proud; A Togias; R M Naclerio; S A Crush; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more
  3 in total

1.  A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Authors:  W C Wolf; D M Evans; L Chao; J Chao
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.

Authors:  Daniel C Pimenta; Sandro E Fogaça; Robson L Melo; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

3.  Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.

Authors:  Sandro E Fogaça; Robson L Melo; Daniel C Pimenta; Kazuo Hosoi; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.